The NPs retained the protein functionality at the surface, as shown by the indirect antibody labeling and the receptor-blocking experiments, and the combination of the PDA with Tf could be used to actively target the B16F10 mouse melanoma cells in vitro, because of the upregulated Tf receptors on the surface of cancer cells. The gene discussed is TF; the disease is cancer.